Cargando…
Immune responses to COVID-19 vaccines in patients with cancer: Promising results and a note of caution
SARS-CoV-2 vaccines are effective in preventing COVID-19. Patients with cancer are at high risk for severe COVID-19 and are appropriately prioritized for vaccination. Several studies in this issue of Cancer Cell add to our knowledge of the heterogeneity of immune responses to vaccination among patie...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier Inc.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8253695/ https://www.ncbi.nlm.nih.gov/pubmed/34242573 http://dx.doi.org/10.1016/j.ccell.2021.07.001 |